Statin combined with exercise training is more effective to improve functional status in dyslipidemic older adults

Scand J Med Sci Sports. 2018 Dec;28(12):2659-2667. doi: 10.1111/sms.13284. Epub 2018 Sep 19.

Abstract

Background: Exercise training (EX) and statins are first-line therapies to manage dyslipidemia.

Purpose: This study aims to analyze the effect of EX and statins on functional status and cardiovascular risk (CVR) in dyslipidemic older adults with comorbidities.

Methods: Participants (n = 981) underwent one of 3 conditions: (a) multicomponent exercise training (EX; n = 298; 74% females); (b) statins (ST; n = 178; 65% females); (c) combined therapy-exercise plus ST therapy (ST+EX; n = 505; 79% females). Functional fitness, anthropometry, hemodynamic and lipid profiles, and were assessed at baseline and after 2-years.

Results: EX and ST+EX participants improved all the functional status variables, whereas ST participants aggravated all the outcomes. Triglycerides and HDL-cholesterol maintained unchanged and total cholesterol decreased in the three groups, whereas LDL-cholesterol (LDL-C) decreased in EX and ST+EX groups but not in ST group. EX and ST+EX groups decreased body mass index (BMI), systolic and diastolic blood pressure; contrarily, ST group increased these variables.

Conclusion: Statins combined with exercise training or exercise alone are more effective to improve functional status, to manage cholesterol levels and overall cardiovascular risk factors in dyslipidemic older adults with comorbidities than ST alone. Furthermore, current results suggest that isolated statin therapy decreases functional status and other cardiovascular risk factors.

Keywords: exercise; functional status; older adults; statins.

MeSH terms

  • Aged
  • Body Mass Index
  • Cardiovascular Diseases / prevention & control
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Cohort Studies
  • Dyslipidemias / therapy*
  • Exercise Therapy*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Middle Aged
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Triglycerides